Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Michael Retsky

Michael Retsky

Harvard TH Chan School of Public Health UK

Jan Jacques Michiels

Jan Jacques Michiels

University Hospitals Antwerp Netherlands

Stephan Grupp

Stephan Grupp

Childrens Hospital Philadelphia USA

Michael Keng

Michael Keng

University of Virginia,  USA

Diana Anderson

Diana Anderson

University of Bradford UK

Olfat M. Hendy

Olfat M. Hendy

Menoufia University Egypt

Stewart Sell

Stewart Sell

Wadsworth Center USA

Elena Zakharova

Elena Zakharova

Botkin Memorial Teaching Hospital  Russia

Oncology Research 2017

Welcome Message

About Conference

ConferenceSeries Ltd invites all the participants across the globe to attend the "8th International Conference on Blood and Oncology Research” slated on June 26-27, 2017 London, UK.

Theme: We share something that kills Cancer

Dates: June 26-28, 2017

Venue: London, UK.

Blood & Oncology Research 2017 conference will be organized by OMICS International along with its subsidiary ConferenceSeries Ltd  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

ConferenceSeries Ltd is the leading international conference organizer and open access publisher which hosts numerous Cancer Conferences like blood cancer conference, skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and oncology conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend Oncology Research 2017?

This unique international conference provides a platform for researchers and decision makers in Oncology research to present their latest findings and learn about all the important developments in cancer specially blood cancer research. Many scientists and world's renowned experts will participate in the conference. Throughout the course of the three day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate cancer research communities.

Target Audience





Hematology Associations & Societies


Research Scholars


Business Entrepreneurs

Software Developing Companies

Medical Devices Companies

Biomedical Companies

Biotechnology Companies

Data Management Companies

In addition to producing our own oncology meetings, cancer conferences, cancer meetings, oncology conferences  we cooperate with national oncology associations and institutes, cancer leagues and other local groups to ensure the highest academic standards in their programs and to stimulate continuing medical oncology education and training.


ConferenceSeries Ltd is glad to welcome all the interested participants to its 8th International Conference on Blood and Oncology Research during June 26-27, 2017 at London, UK. The conference will be organized around the theme “We share something that kills Cancer”. Oncology Research 2017 welcomes the hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Oncology Research 2017 will be an initiative to find the weapon to fight against the dreadful cancers, to protect and save lives. Discussions will be focused on the different types of cancers, mainly blood cancer possibility of early detection and treatment at the advanced stages of these cancers to prolong life.

Track 1Oncology

Oncology is a branch of medicine that deals with tumours. A medical expert who practices oncology is an oncologist. Oncologists may isolate on the origin of the sort of action provided to treat the cancer. A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy. A surgical oncologist eliminates the tumor and nearby tissue during an operation. A radiation oncologist treats cancer using radiation therapy. Gynaecologic oncology is efforts on different cancers of the female reproductive system. Molecular oncology is the study of chemistry of cancer and tumor cell at its molecular cell. Oncologists may divide on the basis of the type of treatment provided to treat the cancer.

Track 2Organ Specific Cancer

Cancer is the term given to a collection of related diseases. Numerous malignancies shape strong tumours, which are masses of tissue. Cancer of the blood, for example, leukaemia, for the most part don't shape strong tumor. Cancerous tumours are malignant, which means they can spread into, or invade, nearby tissues. There are various types of cancer most common type of cancer on the list is breast cancer.

Track 3: Veterinary Oncology

Veterinary oncology is scopes of veterinary drug that arrangement with tumor conclusion and treatment in animals. Cancer is a noteworthy reason for death in pet animals. A veterinary oncologist is a veterinarian who has finished extra particular preparing in customary oncology. A general drug and surgery entry level position is required, in addition to a residency in their picked center: chemotherapy (oncologist), surgery (surgical oncologist), or (radiation oncologist). Buddy animals, for example, dogs and cats experience the ill effects of a significant number of indistinguishable sorts of cancer as human being.

Track 4Cancer Causes and Preventions

Metastasis, or metastatic ailment, is the spread of a malignancy or other infection starting with one organ or part then onto the next not specifically associated with it. An oncovirus is an infection that can bring about tumor. This term started from investigations of intensely changing retroviruses, regularly called oncornaviruses to signify their RNA infection beginning. Physical and Chemical Agents are changes the genetic material like DNA of a living beings that can changes the elucidation and interpretation and DNA replication which can drives cell death.

Tumor Vaccines uses to treat the development the disease might exist malignancy or keeps the progression malignancy. Nourishment and disease great sustenance is imperative to the tumor patients its offers quality to the general population. Changes in Lifestyle are likewise aware to increments in the growth rates like smoking drinking no physical action.

Track 5: Cancer Diagnosis and Diagnostics

Most tumours are at first perceived either in view of the presence of signs or manifestations or through screening. Neither of these prompts to a complete conclusion, which requires the examination of a tissue test by a pathologist. Individuals with suspected cancer are examined with medicinal tests. Diagnostic testing involves tests and procedures to confirm the presence of cancer and identify the correct tumor type, location, extent and stage. Cancer treatment use sophisticated diagnostic technology to pinpoint and evaluate tumours, and develop a personalized treatment plan.

Track 6: Cancer Treatment and Therapeutics

A sort of treatment that utilizations drugs or different substances to recognize and assault particular sorts of cancer cells with less damage to typical cells. Some focused on treatments obstruct the activity of specific compounds, proteins, or different atoms required in the development and spread of growth cells. Different short of targeted therapies help the immune system kill cancer cells or deliver toxic materials directly to cancer cells and kill them. Targeted treatment may have less reactions than different sorts of malignancy treatment. Most focused on treatments are either little particle medications or monoclonal antibodies.

Therapeutics appropriately refers to the utilization of medications and the strategy for their organization in the treatment of cancer. Cancer therapeutics a joined train of medicinal oncology, which might be characterized as the non-surgical, non-radio therapeutic administration of patients with strong tumours and clinical pharmacology, in light of great cytotoxic chemotherapy and the new flag transduction inhibitors.

Track 7: Cancer and Pharmacology

Cancer Pharmacology is at the interface of portraying key procedures in growth science and comprehension the systems of activities of specialists that regulate expansion, survival, mutagenesis, and tumorgenesis. Different research methodologies are being utilized and run from present day strategies in cell and atomic science utilizing as a part of vitro model frameworks to in vivo models of carcinogenesis to front line scientific ways to deal with distinguish and measure DNA adducts and transformations. For the most part, a multiplying or more in plasma drug focus the potential for upgraded antagonistic or valuable medication reaction Drug cooperation in oncology are of specific significance attributable to the tight healing list and the immutable lethality of anticancer specialists.

Track 8Biomarkers

A cancer biomarker can be a procedure substance that demonstrates the nearness of tumor in the body. It might be a particle discharged by tumor cells or a specific reaction of the body as a result of the nearness of growth. Biomarkers may hereditary, epigenetic, proteomic, glycomic, or imaging. They can be utilized for disease analysis, forecast, medication, the study of disease transmission of malignancy. Those biomarkers that are especially connected with transformations offer a quantitative approach to decide when people are inclined to specific sorts of diseases. In numerous ranges of pharmaceutical, biomarkers are restricted to proteins identifiable or quantifiable in the blood or urine. In any case, the term is frequently used to cover any atomic, biochemical, physiological, or anatomical property that can be evaluated or measured.

Track 9Hematology

Hematology involves with the study, diagnosis, treatment, and prevention of diseases related to the blood. The study is based on treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation.

Track 10Haematologic Oncology

Blood malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukaemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes. The other types of Blood Malignancies also include sarcoma, lymphodema, Non-Hodgkin lymphoma (NHL) and lymphoma, lymphoid cancer, bone marrow cancer.

Track 11Blood Cancer

The cause is usually different from other types of cancer. Experts say that Blood Malignancies arise due to different causes, some of them are suspected and some are yet to be. It is nearly impossible to prove what caused a blood cancer in any individual, because most blood cancers have multiple possible causes.

Discussions will be carried out on the suspecting and suspected causes of blood cancer that include: Exposure to radiation and chemicals, Genetic predisposition, drugs, Human T-cell Leukemia Virus (HTLV), Electromagnetic energy, Genetic factors (chromosomal abnormalities, maternal fetal transmission rare).

Track 12Breast Cancer

Breast malignancy begins when cells in the bosom start to become wild. These cells for the most part shape a tumor that can frequently be seen on an x-beam or felt as a knot. The tumor is dangerous (disease) if the cells can develop into (attack) encompassing tissues or spread (metastasize) to inaccessible zones of the body. Bosom growth happens totally in ladies, yet men can get breast cancer, as well.

Hazard elements for creating breast tumor incorporate being female, weight, absence of physical work out, drinking liquor, hormone substitution treatment amid menopause, ionizing radiation, early age at first period, having youngsters late or not in the least, more established age, and family history.

Track 13:  Gynaecologic Cancer

A gynecologic oncologist is an obstetrician/gynecologist who works in the analysis and treatment of ladies with tumor of the conceptive organs including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. With a specific end goal to wind up distinctly a gynecologic oncologist in the United States, a doctor should first entire an endorsed, 4-year residency program in obstetrics and gynecology. Taking after this, he/she should finish a 2–4 year clinical partnership in gynecologic oncology.

Track 14Blood Disorders

CBlood Disorder is a condition in which there's an issue with red blood cells, white blood cells, or the littler, circulating cells called platelets, which are basic for cluster arrangement. Each of the three cell sorts shape in the bone marrow, which is the delicate tissue inside bones. Blood disorders can also affect the liquid portion of blood, called plasma.

Track 15Immunology

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumour marker-based diagnostic tests. These scientific sessions will include the discussion on various topics such as Immunotherapeutic approaches, immune tolerance and deficiencies, Anti-Blood Cancer Factor and immunotherapy.

Track 16Oncology Nursing

An Oncology Nurse gives care to malignancy patients and those at hazard for getting the malady. They screen physical conditions, recommend solution, and oversee chemotherapy and different medicines. Oncology nursing frequently serves as your first line of correspondence, and help to organize the numerous parts of your care all through growth treatment.

Track 17: Cancer Epidemiology

Cancer epidemiology is concerned with the estimation and study of cancer and its prevalence in a certain area of population, to conclude the possible trends, causes of cancer and develop improved treatments by the use of epidemiological methods. Cancer epidemiology is principally concerned with the study of cancer, its causes, detection, and treatment based on the progression of the disease. 

Track 18: Clinical Trials and Case Report

A case report is a detailed report consisting the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. A case report is generally considered a type of evidence of the work carried out and the output attained.

Case studies are extremely useful records of the clinical practices of a profession. They are a record of clinical interactions which help us to frame questions for more rigorously designed clinical studies. Case studies also provide valuable teaching material, demonstrating both classical and unusual presentations which may challenge the practitioner.

Track 19: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

Market Analysis

Market Analysis Report:

Cancer is a disease in which abnormal cells divide uncontrollably and destroy body tissue.  There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery.

Cancer is a complex medical issue that requires a multidisciplinary approach. This approach is sweeping and ranges from well-being advancement to counteractive action and screening, diagnosis, treatment, restoration and palliative care.

Importance & Scope

Oncology Research 2017 will be the best platform for all the oncologists, haematologists, research scholars, students who are working in this field to exchange their knowledge related to Blood & Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability, and quality of life.

Specialists will clarify how another era of treatment alternatives gives patients new trust in the battle against cancer.

Geologically, the worldwide cancer treatment market is grouped into locales to be specific, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Middle East, Japan, and Africa. North America takes the biggest share of worldwide cancer growth treatment approximately 42% showcase took after by Europe approx. 26%. The worldwide oncology treatment market is required to develop in future because of expanding venture by multinational organizations in cancer look into.


Why London?

London is the capital and most crowded city of England and the United Kingdom with inhabitant populace of 7,500, making it the littlest city in England. Remaining on the River Thames, London has been a noteworthy settlement for two centuries.

London is a main worldwide city, with qualities of heritage, expressions, trade, training, diversion, fashion, fund, innovative work, social insurance, media, proficient administrations and tourism. In UK more than 90 Universities/schools, 200 pharmaceutical organizations, and more than 80 Associations and social orders are taking a shot at Cancer and other blood related scatters. Subsidizing awards by the legislature of china for research almost 200 million USD$ to colleges and 1.5 billion USD$ to the pharmaceutical and research establishments.

Conference Highlights:

·         Oncology

·         Cancer

·         Cancer Causes and Preventions

·         Cancer Diagnosis and Diagnostics

·         Cancer Treatment and Therapeutics

·         Cancer and Pharmacology

·         Biomarkers

·         Hematology

·         Haematologic Oncology

·         Breast Cancer

·         Blood Cancer

·         Blood Disorders

·         Immunology

·         Cancer Epidemiology

·         Clinical Trials and Case Report

·         Entrepreneurs Investment Meet

Why to attend..??

This exceptional universal meeting gives a stage to scientists and leaders in cancer research to display their most recent discoveries and find out about all the imperative advancements in disease investigate. Numerous researchers and widely renowned specialists will participate in the meeting. Over the course of the two day meeting, you will have the chance to both network and hear pioneers from the global scholastic and corporate cancer investigate groups.

Target Audience

Oncology Research 2017 welcomes the oncologists, hematologists, immunologists, pathologists, research scholars, doctors/clinicians, industrial professionals, student delegates and cancer associations & societies from biomedical and healthcare sectors to be a part of it.


Major Associations

In London

Cancer Research UK

Children with Cancer UK

United Kingdom Association of Cancer Registries

Children’s Cancer and Leukaemia Group

Leukaemia Cancer Society

Lymphoma Association

Leukaemia & Lymphoma Research

Myeloma UK

Leukaemia CARE


American Cancer Society (ACS)

Hematology/Oncology Pharmacy Association

Cancer Research Institute, USA

National Cancer Institute (USA)

American Society of Haematology

American Association for Cancer Research (AACR)

Association of International Cancer Research

National Cancer Institute

Lymphoma Research Foundation, USA

National Children’s Leukaemia Foundation, USA

International Myeloma Foundation

National Children's Leukemia Foundation

Childhood Leukemia Foundation

Cancer and Leukemia Group B

International Agency for Research on Cancer (IARC)

Union for International Cancer Control (UICC)

Prevent Cancer Foundation

American Childhood Cancer Organisation


Union for International Cancer Control

International Fanconi Anemia Registry (IFAR)

Armenian Association of Hematology & Oncology

Cancer Association of South Africa

Canadian Cancer Sociey

Society for Paediatric Oncology & Hematology

Chinese Society of Clinical Oncology

Cancer Research UK

Indian Association of blood cancer & Allied Diseases

The Leukaemia and Lymphoma Society of Canada

Leukaemia Cancer Society

Leukaemia & Blood Cancer New Zealand

Korean Cancer Association

Fanconi Anaemia Australia

Leukaemia Foundation of Australia

Indian Cancer Society

Brazilian Lymphoma & Leukaemia Association

Chronic Myelogenous Leukaemia Society of Canada

Children’s Cancer and Leukaemia Group

German Cancer Society

Lymphoma Foundation Canada

Cancer Society of Finland

France Lymphoma Hope

Leukaemia &Blood Cancer, New Zealand

Medical Oncology Group of Australia

Australian & New Zealand Children’s Hematology/Oncology Group

Childhood Cancer Research Group, UK

National Cancer Institute of Argentina

Cancer Society Nepal


Top Universities

In London

University of Oxford

University of Cambridge

King's College London

UCL Medical School

Queen Mary, University of London

Imperial College, London

Institute on Cancer Research

St. George’s, University of London

The University of Sheffield



Harvard University

Stanford University

Cambridge University

Mayo Medical School, US

John Hopkins University

Yale University

University of Colorado

St. George’s University

Emory University

University of California

University of Maryland, Baltimore

North-western University, IIlinois

University of Texas

Massachusetts Institute of Technology (MIT)

Carnegie Mellon University, United States of America

University of Pennsylvania, Philadelphia

Indiana University School of Medicine, Melvin and Bren Simon Cancer Center

University of Rochester, New York

Cornell University, United States of America

Baylor COLLEGE of medicine US

Columbia University, New York

University of Iowa

Princeton University, US

University of Minnesota Medical Center

University of Auckland

University of Michigan

University of Melbourne

Ohio State University, Columbus

Rockefeller University, US


University of Chicago, Chicago

University of Toronto, Canada

Washington University in St. Louis

Thomas Jefferson University

National University of Singapore (NUS), Singapore

Indianapolis University “La Sapienza” of Rome, Rome, Italy

University of Wisconsin, Madison-

University of Tokoyo, Japan

Guangxi Medical University, Nanning, China

University of Lyon, France

University Of Leeds

University Of Queensland,Australia

University of Arizona Cancer Center

University of Utah

Georgetown University Medical Center

 University of Southampton

University of Pittsburgh

 McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine

University of Alberta

University Of British Columbia

University Of Leicester

 University Of Chester

University of Kentucky

University of north Durham

 University Of Surrey

 University Of Edinburgh

 University of Glasgow

 University Of Bordeaux,France

Oregon Health and Science University

 Knight Cancer Institute

Loyola University Chicago

University oF Louisville

 University of Toledo

Rutgers University

University Of Calgary

University Of Witaterstrand

University Of Western Sydney, Australia

University of Melbourne

University Of South Australia

University Of New South Wales

Monash University, Australia

University of Milan, Italy

Kyoto University, Japan

The University of Auckland, NZ

University Of Zurich

National Taiwan University

The University of Manchester, UK

Ichan School of medicine, Mount Sinai

Pondicherry University, India

University of phoenix

Griffith University

University Of Exeter

Crimea State Medical University,Ukriane

 Heidelberg University

 Hackensack University Medical Center

 Kyoto University, Taiwan

 Osaka University, Japan

 Kursk State Medical University, Russia


Roche group is one of the main suppliers of cancer growth treatment drugs. A portion of the key players in cancer treatment market are Novartis Pharmaceuticals, Celgene Corporation, Merck & Co., Bristol-Myers Squibb Company, AbbVie Inc., Johnson and Johnson Pvt. Ltd., Amgen Inc., Teva pharmaceutical Industries Ltd., Bayer AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd.

Market Analysis report

The market of cancer is communicated to show unfaltering development rate amid the estimate time frame from 2015 – 2020. This development is driven by main considerations, for example, rising predominance of different infections and broad R&D practices are progressing over the globe to bring new and more successful medications and plans in the market.

Progression in innovation customized pharmaceutical, financially savvy treatment methods are couple of different components anticipated to keep up the development of worldwide cancer treatment showcase. However, unique nature of blood diseases and expanding stringency in the administrative prerequisites are a portion of the real restrictions constraining the development of worldwide tumor treatment showcase.


The worldwide market for Oncology medications was assessed to be $25.8 billion in 2015. By 2017, the market is relied upon to reach $42.5 billion, developing at a CAGR of 12% in the vicinity of 2015 and 2017. The aggregate worldwide market for oncology issue medications and diagnostics in 2015 was assessed at almost $82.3 billion. By 2017, the market is relied upon to reach $99.3 billion, developing at a compound yearly development rate (CAGR) of 7.2% in the vicinity of 2015 and 2017. The worldwide cancer issue advertise section is evaluated at $53.3 billion in 2015 and is relied upon to reach about $76.7 billion by 2017. The real purpose behind the low development rate is the normal decrease in the yearly cost of treating cancer issue and the patent lapses of Lovenox, Plavix, Procrit/Epogen, Aranesp, and Neulasta. In 2010, every one of these medications together achieved income of $32 billion into the worldwide blood issue advertise.

Past Conference Report

World Cancer 2016

We extend a heartily thanks to all of our wonderful speakers, conference attendees as the World Cancer 2016 Conference was a great success!!

Conferenceseries LLC hosted the “12th World Cancer Conference” during September 26-28, 2016 at Hilton Heathrow Airport Hotel, London, UK. The conference was focused on Cancer & Oncology studies with the theme “Integrating every bit of cancer research: Prevention, diagnosis and cure”. Generous response and active participation was received from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2016 from Cancer & Oncology Conferences

The conference was initiated with Opening Ceremony followed by with a series of lectures delivered by both Honourable Guests and members of the Keynote forum.

The list included:

·         Alvaro Macieira-Coelho, French Institute of Health and Medical Research, France

·         Liane Deligdisch, Mount Sinai School of Medicine, USA

·         Katharina Pachmann, SIMFO GmbH Bayreuth, Germany

·         Ella L Kim, Johannes Gutenberg University Medical Centre, Germany

·         Qingyong Ma, Xi’an Jiaotong University, China

·         Sabine Mai, University of Manitoba, Canada

·         Nichola C Garbett, University of Louisville School of Medicine, USA

·         Alain Charest, Harvard Medical School, USA


We heartily acknowledge the conference moderator Dr. Jessie for her support for the conference. We are also gratified to various outside experts, company representatives and other renowned personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards World Cancer 2016

Trailing the success of World Cancer 2016, Conferenceseries LLC would like to announce the initiation of the “25th World Cancer Conference” to be held during October 19-21 at Rome, Italy


Past Reports  Proceedings  Gallery  

Oncologists 2016

The success of the Oncologists  2016 conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “10th Global Annual Oncologists Meeting” during July 11-13, 2016 at Park Inn by Radisson Köln City West, Cologne, Germany

The conference was focused on learning about Oncologists with the theme “To Say There is Life after Cancer.The conference mainly directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 is one of the most appreciated Cancer Conferences organized by Conferenceseries LLC. This Oncologists Meeting was discussed on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:


  • Dr. Diana Anderson, University of Bradford, UK
  • Dr. Karl Reinhard Aigner, Medias Klinikum GmbH & Co KG, Germany
  • Dr. Hirendranath Banerjee, Elizabeth City State University, USA
  • Dr. Ajay Singh, Mitchell Cancer Institute, USA
  • Dr. Matin Burrow, DMB-Diagnostics GmbH, Germany
  • Dr. Martin Kristensson, Visiopharm, Denmark
  • Dr.Michael Retsky, Harvard TH Chan School of Public Health, USA


Conferencesereies LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferencesereies LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Oncologists 2016, Conferencesereies LLC would like to announce the commencement of the “16th Global Annual Oncologists Meeting” to be held during April 24-25, 2017 Dubai, UAE. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology and cancer Research.


Past Reports  Proceedings  Gallery  

Cancer Therapy 2015

Thanks to all our admirable speakers, conference attendees contributed to the success of 5th World Congress on Cancer Therapy organized by OMICS International during September 28-30, 2015 Atlanta, Georgia, USA with the theme Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers which was a great success where eminent keynote speakers from various reputed universities, institutions and hospitals with their splendid presence addressed the gathering.

OMICS International would like to convey a warm gratitude to all Honorable Guests and Keynote Speakers of Cancer Therapy-2015:

Jack C. Westman, University of Wisconsin School of Medicine, USA

Erwin G. Van Meir, Winship Cancer Institute, USA

Yoshiaki Omura, New York Medical College, USA

Michael Weber, Weber Medical, Germany

Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

A review of cancer immunotherapies and nutritional therapies: Jack C. Westman, University of Wisconsin School of Medicine & Public Health, USA BAI1 is a brain-specific tumor suppressor: Erwin G. Van Meir, Winship Cancer Institute, Emory University, USA

New simple method of detecting various cancers & their biochemical information from rapidly changing part of QRS complex of ECGs and its clinical application for screening and evaluation of cancer: Yoshiaki Omura, New York Medical College, USA

Systemic and interstitial photodynamic laser therapy: New options in oncology: Michael Weber, Weber Medical, Germany

Chemoprevention of experimental mammary carcinoma by Trianthe ma portulacastrum Linn., an Indian dietary and medicinal plant: Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA

The meeting was executed through various sessions, in which the discussions were held on the following major scientific tracks:

Cancer Cell Biology, Diagnosis and Applied Research

  • Organ-Specific Cancer
  • Advances in malignancy counteractive action and screening
  • Anti-cancer drugs and delivery
  • Novel Approaches to Cancer Therapeutics
  • Cancer Therapy and Clinical Cancer Research
  • Chemotherapy
  • Cancer and Lifestyle Connection
  • Complementary and Alternative Medicine (CAM)
  • Cancer Biomarkers
  • Cancer Vaccines
  • Cancer Nanotechnology
  • Global Cancer Epidemiology
  • Cancer Pharmacology
  • Cancer Stem Cell Therapy
  • Cancer Chemotherapy
  • Pediatric Oncology
  • Clinical Oncology
  • Gastrointestinal Cancer
  • Gynecological Cancer
  • Radiation Oncology
  • Surgical Oncology
  • Tumor Virology
  • Anti-cancer Agents in Medicinal Chemistry
  • Cellular Pathology
  • Cancer Metabolomics
  • Tumor immunology & immunotherapy

Cancer Therapy 2015 Organizing Committee would like to thank the Moderator of the conference, Sherri Z. Millis from Advanced Individual Medicine, LLC USA who contributed a lot to the smooth functioning of this event.

OMICS International, on behalf of the Cancer Therapy 2015, congratulates the best poster awardee, Sitelbanat Yassin, China Pharmaceutical University, Chinafor her outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavors. Also, we would like to thank the poster evaluation committee member Amy McCullough from American Humane Association, USA for his valuable support and advice.

OMICS International is honored to felicitate Cancer Therapy 2015 Organizing Committee and Editorial Board Members of Journal of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Chemotherapy, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Therapy 2015, OMICS International is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, 14th World Congress on Cancer Therapy to be held during June 5th - 7th, 2016 at Philadelphia, USA.


Past Reports  Proceedings  Gallery  

Cancer Middle East 2015

OMICS International’s 7th Global Summit on Cancer Therapy at Dubai, UAE October 05-07, 2015 was organized with a focus on Critical Review on “Rising helpful advances in cancer sorts” was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Cancer Middle East-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of Cancer research.

Cancer Middle East-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Terence B Culas, Government Medical College Palakkad, India, who contributed a lot for the smooth functioning of this event.

OMICS International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Cancer Middle East-2015.

Keynote Speakers of Cancer Middle East-2015:

Fritz Lahrtz, Isenbruck Bösl Hörschler LLP Prinzregentenstr, Germany

Ioannis Papasotiriou, RGCC International GmbH, Switzerland

Yunus A Luqmani, Kuwait University, Kuwait

Sadir J Alrawi, Tawam Hospital, UAE

OMICS International, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Deepak Kaul, Post Graduate Institute of Medical Education and Research, India for his valuable time.

Best Poster Winners:

Mariam Ahmed Fouad, Cairo University, Egypt

Nooshin Nourbakhsh, Isfahan University of Medical Sciences, Iran

OMICS International also took the privilege of felicitating Cancer Middle East-2015 Organizing Committee, Editorial Board Members of Journal of Cancer Science & TherapyJournal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Middle East-2015, OMICS International Conferences is glad to announce

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 26-28, 2017

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Cancer Science & Therapy Journal of Leukemia Journal of Blood Disorders and Transfusion

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by